Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial

In conclusion, the noninferiority criterion for pathogen-inactivated platelets was met in the intention-to-treat analysis. This finding was not demonstrated in the per-protocol analysis. This trial was registered at The Netherlands National Trial Registry as #NTR2106 and at www.clinicaltrials.gov as #NCT02783313.

Source: Blood - July 12, 2018 Category: Hematology Authors: van der Meer, P. F., Ypma, P. F., van Geloven, N., van Hilten, J. A., van Wordragen-Vlaswinkel, R. J., Eissen, O., Zwaginga, J. J., Trus, M., Beckers, E. A. M., te Boekhorst, P., Tinmouth, A., Lin, Y., Hsia, C., Lee, D., Norris, P. J., Goodrich, R. P., Br Tags: Thrombocytopenia, Transfusion Medicine, Transplantation, Platelets and Thrombopoiesis, Thrombosis and Hemostasis, Clinical Trials and Observations Source Type: research